Key Themes & Topics
RNA Therapeutics & Delivery
Advancing mRNA, saRNA, and circRNA innovation with next-generation LNPs and non-viral delivery technologies designed to enhance RNA stability, translation efficiency, and manufacturability.
RNAi, ASOs & Gene Silencing
Exploring cutting-edge RNA interference platforms, antisense oligonucleotide design, and precision gene-silencing strategies for targeted therapeutic applications.
Computational RNA Design & Predictive Analytics
Leveraging AI-driven modelling, computational optimisation, and predictive analytics to accelerate RNA design, stability profiling, and therapeutic performance.
Vaccine Innovation & Platforms
Covering breakthroughs across mRNA, DNA, viral vector, and recombinant vaccine platforms, supported by advanced antigen discovery and structural biology insights.
Next-Generation Adjuvants & Immunomodulators
Showcasing novel adjuvant systems and immunomodulatory technologies engineered to boost vaccine potency, durability, and cross-protection.
Therapeutic Vaccines
Focusing on cancer, autoimmune, and chronic disease vaccine development, with an emphasis on emerging mechanisms, clinical translation, and combination modalities.
Biologics Formulation & Delivery Science
Innovating around high-concentration biologics, viscosity management, and stabilisation strategies for mAbs, bispecifics, and ADCs.
Smart & Patient-Centric Delivery Systems
Highlighting microneedles, depots, microspheres, and advanced subcutaneous platforms enabling patient-friendly, self-administered biologics.
Lyophilisation & Excipient Engineering
Optimising lyophilisation cycle design, excipient selection, and aggregation control to improve biologic stability and long-term formulation robustness.
Manufacturing, Stability & Analytical Excellence
Covering process scale-up for RNA vaccines and biologics alongside advanced characterisation techniques including MS, NGS, and real-time stability analytics.
Quality, Regulatory & GMP Frameworks
Ensuring regulatory compliance through enhanced quality systems, GMP strategies, and risk-based approaches for accelerated, reliable product development.
WHO
For biopharma biotech and pharmaceutical leaders across Europe working in RNA design vaccine R and D biologics formulation drug delivery and stability science. This includes R and D Drug Product Analytical Development CMC Quality and Manufacturing professionals from leading pharmaceutical companies innovative biotechs CDMOs technology providers and academic research institutions.
WHAT
A strategic platform dedicated to advancing the next generation of biologics formulation stability and delivery. BioFormulate Live 2026 unites three concurrent scientific streams RNA Therapeutics Vaccine Innovation and Biologics Formulation and Delivery offering deep technical insights spanning early development through commercial scale production.
WHY
To accelerate innovation in biologics drug development by bringing together top scientific technical and regulatory experts. Attendees gain practical solutions to stability challenges formulation optimisation patient focused delivery and manufacturing scale up. The event enables high value collaboration technology discovery and future focused insights at the junction where formulation science meets global healthcare impact.
Senior Attendees
Meet a concentrated audience of biologics RNA and vaccine development leaders from global pharma biotechs CDMOs and academia.
Expert Speakers
Hear from world class leaders in RNA engineering formulation science structural biology vaccine innovation and drug product development.
Companies Represented
A pan European gathering representing biopharma technology providers regulatory bodies and academic institutions.
